These studies have shown that LDLR overexpression enhance uptake and clearance of Aβ by astrocytes, while deletion of LDLR results in decrease in Aβ uptake, suggesting the potential of LDLR gene as a therapeutic target for Alzheimer’s disease. The gene discussed is LDLR; the disease is early-onset autosomal dominant Alzheimer disease.